Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Department of Clinical Epidemiology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Endocr Pract. 2021 Aug;27(8):819-825. doi: 10.1016/j.eprac.2021.03.014. Epub 2021 Apr 6.
To estimate the association of maternal thyroid dysfunction with the risk of gestational hypertension and diabetes. Whether the association was affected by gestational age at diagnosis and thyroid autoimmunity was further explored.
A cohort study of 41 647 participants was conducted. Thyroid function (ie, thyroid-stimulating hormone [TSH] and free thyroxine [FT4]) was measured by electrochemiluminescence immunoassay. Thyroid antibody positivity (eg, thyroperoxidase, thyroglobulin, and TSH receptor antibody) was indicated if the values of these antibodies exceeded the upper targets of the reference range. The relationship between maternal thyroid dysfunction and the risk of pre-eclampsia (PE) and gestational diabetes mellitus (GDM) was assessed by multivariate logistic regression.
Isolated hypothyroxinemia (defined as 5th ≤ TSH ≤ 95th percentile, FT4 < 5th percentile) was associated with the risk of PE (odds ratio [OR], 1.32; 95% CI, 1.10-1.58). Overt hypothyroidism (TSH > 95th percentile; FT4 < 5th percentile) was related to the risk of severe PE (OR, 2.59; 95% CI, 1.05-6.37). Being positive for TSH receptor antibody was associated with a decreased risk of GDM (OR, 0.49; 95% CI, 0.35-0.70). A marginally significant association between overt hypothyroidism detected at the first trimester and the risk of GDM was found (OR, 1.60; 95% CI, 1.00-2.83). The association of thyroid dysfunction with the risk of PE and GDM was stronger among pregnant women who were negative for autoantibodies.
Some types of thyroid dysfunction during pregnancy were associated with the risk of PE and GDM. The associations varied by gestational age at diagnosis and by thyroid autoantibody status.
评估母体甲状腺功能障碍与妊娠高血压和糖尿病风险的关联。进一步探讨诊断时的孕龄和甲状腺自身免疫对这种关联的影响。
对 41647 名参与者进行了队列研究。通过电化学发光免疫测定法测量甲状腺功能(即促甲状腺激素 [TSH] 和游离甲状腺素 [FT4])。如果这些抗体的值超过参考范围上限,则表明甲状腺抗体阳性(如甲状腺过氧化物酶、甲状腺球蛋白和 TSH 受体抗体)。采用多变量逻辑回归评估母体甲状腺功能障碍与子痫前期(PE)和妊娠期糖尿病(GDM)风险之间的关系。
单纯甲状腺素血症(定义为 5th≤TSH≤95th 百分位,FT4<5th 百分位)与 PE 风险相关(比值比 [OR],1.32;95%CI,1.10-1.58)。显性甲状腺功能减退症(TSH>95th 百分位;FT4<5th 百分位)与重度 PE 风险相关(OR,2.59;95%CI,1.05-6.37)。TSH 受体抗体阳性与 GDM 风险降低相关(OR,0.49;95%CI,0.35-0.70)。在孕早期发现显性甲状腺功能减退症与 GDM 风险之间存在边际显著关联(OR,1.60;95%CI,1.00-2.83)。甲状腺功能障碍与 PE 和 GDM 风险的关联在自身抗体阴性的孕妇中更强。
妊娠期间某些类型的甲状腺功能障碍与 PE 和 GDM 的风险相关。这种关联因诊断时的孕龄和甲状腺自身抗体状态而异。